BDRX Stock Summary and Trading Ideas (Biodexa Pharmaceuticals PLC - American Depositary Shares | NASDAQ:BDRX)

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.

Biodexa Pharmaceuticals PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol BDRX.

As of December 11, 2025, BDRX stock price declined to $6.30 with 478,924 million shares trading.

BDRX has a beta of 0.36, meaning it tends to be less sensitive to market movements. BDRX has a correlation of 0.00 to the broad based SPY ETF.

BDRX has a market cap of $3.90 million. This is considered a Sub-Micro Cap stock.

BDRX has underperformed the market in the last year with a return of -86.5%, while SPY returned +15.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in BDRX shares. However, BDRX has outperformed the market in the last 3 month and 2 week periods, returning +9.9% and +44.8%, while SPY returned +5.9% and +1.4%, respectively. This indicates BDRX has been having a stronger performance recently.

BDRX support price is $5.85 and resistance is $7.59 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BDRX shares will trade within this expected range on the day.